Table 1. Sample characteristics and experimental results.
Sample characters | Results | |||||||
---|---|---|---|---|---|---|---|---|
Sample no. | Age (years) | No. of fetal losses | Without thrombophilia | Positive for anti-PE antibody | Protein S deficiency | Factor XII deficiency | Positive for anti-C9 antibody | C9 (μg/ml) |
1 | 41 | 8 | ○ | 67.18 | ||||
2 | 43 | 3 | ○ | 52.54 | ||||
3 | 30 | 2 | ○ | ○ | 52.54 | |||
4 | 30 | 3 | ○ | ◎ | 70.46 | |||
5 | 40 | 3 | ○ | ○ | ○ | 65.48 | ||
6 | 36 | 7 | ○ | 112.4 | ||||
7 | 35 | 4 | ○ | 47.36 | ||||
8 | 30 | 4 | ○ | 25.06 | ||||
9 | 36 | 3 | ○ | 51.24 | ||||
10 | 37 | 2 | ○ | 21.88 | ||||
11 | 27 | 3 | ○ | 124.04 | ||||
12 | 40 | 5 | ○ | 55.64 | ||||
13 | 43 | 4 | ○ | 47.76 | ||||
14 | 31 | 3 | ○ | 40.1 | ||||
15* | 41 | 3 | ○ | ◎ | 104.62 | |||
16* | 31 | 4 | ○ | ◎ | 67.28 | |||
17* | 30 | 3 | ○ | 53.64 | ||||
18 | 36 | 2 | ○ | 40.8 | ||||
19 | 39 | 6 | ○ | 34.12 | ||||
20 | 39 | 3 | ○ | 29.44 | ||||
21 | 37 | 3 | ○ | 44.98 | ||||
22 | 38 | 3 | ○ | ○ | 45.98 | |||
23 | 40 | 3 | ○ | 45.18 | ||||
24 | 38 | 3 | ○ | 36.8 | ||||
25 | 42 | 4 | ○ | 94.76 | ||||
26 | 33 | 3 | ○ | 56.42 | ||||
Cont 1 | 32 | 0 | 84.42 | |||||
Cont 2 | 30 | 0 | 58.22 | |||||
Cont 3 | 38 | 0 | 32.92 | |||||
Cont 4 | 36 | 0 | 52.34 |
Asterisk indicates pooled SN-APS serum sample.